Search

Search Constraints

You searched for: Author/Creator Feugier, Pierre

Search Results

31. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis. (26th November 2013)

32. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study. Issue 2 (February 2019)

33. Positron Emission Tomography–Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study. Issue 10 (1st April 2022)

34. Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy. Issue 8 (12th May 2021)

35. Real‐world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients. Issue 8 (30th May 2017)

36. Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study. Issue 2 (February 2018)

37. Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience. Issue 6 (1st April 2015)

38. Serum albumin or body mass index: Which prognostic factor for survival in patients with acute myeloblastic leukaemia?. Issue 1 (5th October 2018)

39. Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma. Issue 28 (1st October 2022)

40. Specific treatment modalities for elderly patients with chronic lymphocytic leukemia. (June 2012)